What's Spurring The Growth Of The Psychedelics Market – And How One Company Is Helping As Part Of The Vanguard In This Emerging Field

By Rachael Green

In August, a group of well-known biotech institutional investors participated in an up to almost $300 million financing round for COMPASS Pathways (NASDAQ: CMPS ), consisting of an initial investment of $125 million and the potential for an additional investment of

You are viewing a robot-friendly page.Click hereto reload in standard format.